BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31685833)

  • 21. [Detection of human telomerase RNA component gene by fluorescent in situ hybridization for screening of cervical lesions].
    Gao L; Zhu Y; Liu SP; Gao Y; Zhu MH
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):104-7. PubMed ID: 21426806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
    Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of hTERC and c-MYC genes in cervical epithelial exfoliated cells for cervical cancer screening.
    Li T; Tang L; Bian D; Jia Y; Huang X; Zhang X
    Int J Mol Med; 2014 May; 33(5):1289-97. PubMed ID: 24626956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
    Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
    Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic amplification of hTERC in paraffin-embedded tissues of cervical intraepithelial neoplasia and invasive cancer.
    He C; Xu C; Xu M; Yuan Y; Sun Y; Zhao H; Zhang X
    Int J Gynecol Pathol; 2012 May; 31(3):280-5. PubMed ID: 22498947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
    Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K;
    J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
    Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
    Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of Van-Clear and xylene in the detection of cervical hTERC gene by fluorescence in situ hybridization].
    Chen Z; Wang Y; Mi X; Chen A; Zhong S; Huang H; Xu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):367-73. PubMed ID: 27241146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III.
    Xiang L; Yang H; Li J; Wu X; Zhou X
    Diagn Cytopathol; 2012 Oct; 40(10):849-55. PubMed ID: 21381227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology?
    Kang WD; Ju UC; Kim SM
    Gynecol Oncol; 2018 Feb; 148(2):305-310. PubMed ID: 29183629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association between high risk human papillomavirus DNA load and cervical lesions in different infection status].
    Li TY; Wu ZN; Jiang MY; Cui JF; Liu B; Chen F; Chen W
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):475-480. PubMed ID: 29936777
    [No Abstract]   [Full Text] [Related]  

  • 34. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.
    Andersson S; Sowjanya P; Wangsa D; Hjerpe A; Johansson B; Auer G; Gravitt PE; Larsson C; Wallin KL; Ried T; Heselmeyer-Haddad K
    Am J Pathol; 2009 Nov; 175(5):1831-47. PubMed ID: 19880826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
    J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of human telomerase RNA gene amplification detection for cervical cancer screening.
    Chen SM; Lin W; Liu X; Zhang YZ
    Asian Pac J Cancer Prev; 2012; 13(5):2063-8. PubMed ID: 22901172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions.
    Zhang Y; Wang X; Ma L; Wang Z; Hu L
    J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):368-71. PubMed ID: 19513624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.